Article (Scientific journals)
Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion
Thielen, Caroline; Herens, Christian; Fassotte, Marie-France et al.
2006In European Journal of Haematology, 77 (4), p. 318-326
Peer Reviewed verified by ORBi
 

Files


Full Text
Thielen et al. 2006.pdf
Publisher postprint (771.53 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Burkitt lymphoma; effusion lymphoma; B-cell lines; Epstein-Barr virus; GAL-01; GAL-02
Abstract :
[en] Objectives: Burkitt's lymphoma (BL) is a highly aggressive mature B-cell neoplasm comprising endemic, sporadic and immunodeficiency-associated variants. Human cell lines constitute a very useful tool to investigate the biology of lymphoid neoplasia. In this study, we succeeded in establishing two human cell lines, GAL-01 and GAL-02, from a HIV-negative patient with Epstein-Barr virus (EBV) -negative sporadic BL presenting as an effusion. GAL-01 and GAL-02 were established at diagnosis and after one course of polychemotherapy, respectively. The in vivo effusion occurred in a very peculiar clinical setting; the patient having a previous history of intestinal diffuse large B-cell lymphoma. Methods: The morphologic, immunophenotypic and molecular genetic features of GAL cell lines are reported and compared with those of the parental tumour. The findings clearly demonstrated that the Burkitt effusion did not represent disease progression of the intestinal tumour, but represented a second primary haematological malignancy. The in vivo tumorigenic properties of the cells were tested by subcutaneous injection to NOD/SCID mice. Results: Both cell lines were composed of medium-sized lymphoid cells with clumped chromatin, multiple medium-sized nucleoli and moderate amounts of vacuolated cytoplasm. GAL cells display the phenotype and genotype of a B-cell lineage (positive for CD20, CD79a and clonal rearrangement of Ig heavy chain), carry the c-MYC rearrangement by t(8;22)(q24;q11) translocation and are characterised by the expression of the germinal centre-associated antigens CD10, BCL6, CD38 and absent to low BCL2 expression. EBV and HHV8 were not identified within parental tumour or in cultured cells. Subcutaneous injection of both cell lines to NOD/SCID mice induced tumour formation. Conclusions: GAL-01 and GAL-02, two novel EBV-negative human BL cell lines represent a potentially useful experimental model to study the biology of BL possibly including the resistance to chemotherapy.
Research center :
Giga-Cancer - ULiège
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège
Disciplines :
Hematology
Author, co-author :
Thielen, Caroline ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Herens, Christian ;  Centre Hospitalier Universitaire de Liège - CHU > Génétique
Fassotte, Marie-France ;  Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Detrooz, Elisabeth;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Drion, Pierre ;  Université de Liège - ULiège > Centre animalier universitaire - Animalerie centrale
Diss, T.
Boniver, Jacques ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
de Leval, Laurence ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Language :
English
Title :
Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion
Publication date :
October 2006
Journal title :
European Journal of Haematology
ISSN :
0902-4441
eISSN :
1600-0609
Publisher :
Blackwell Publishing, Oxford, United Kingdom
Volume :
77
Issue :
4
Pages :
318-326
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Fondation contre le Cancer [BE]
Fonds Léon Fredericq [BE]
Available on ORBi :
since 18 December 2008

Statistics


Number of views
101 (10 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
1
OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi